Abstracts Archive - Page 2172 of 2605 - ACR Meeting Abstracts

Abstract Number: 897 • 2014 ACR/ARHP Annual Meeting
Resting State Functional Connectivity Differs Between Chronic Fatigue Syndrome Patients and Healthy Controls
Jason Craggs¹, Charles Gay¹, Andrew O'Shea¹, Ricky Madhavan², Donald Price³, Michael Robinson¹ and Roland Staud⁴, ¹Clinical & Health Psychology, University of Florida, Gainesville, FL, ²Medicine/Rheumatology, University of Florida, Gainesville, FL, ³Maxillo-Facial Surgery, University of Florida, Gainesville, FL, ⁴Dept Med/Rheum/Clin Immun Div, Univ of Florida Med Ctr/JHMHC, Gainesville, FL
Background/Purpose: Examining neural activity in the absence of task (i.e. resting state) is an active area of research. Functional connectivity, defined as correlations in BOLD…
Abstract Number: 893 • 2014 ACR/ARHP Annual Meeting
Polysymptomatic Distress Categories for Clinical and Research Use
Frederick Wolfe¹, Brian T. Walitt², Johannes Rasker³, Robert S. Katz⁴ and Winfried Häuser⁵, ¹National Data Bank for Rheumatic Diseases, Wichita, KS, ²Rheumatology, Washington Hospital Center, Washington, DC, ³Dpt. Psychology, Health and Technology, University Twente, Enschede, Netherlands, ⁴Rush Medical College, Chicago, IL, ⁵Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: The polysymptomatic distress (PSD) scale is derived from variables used in the 2010 American College of Rheumatology (ACR) fibromyalgia (FM) criteria as modified for…
Abstract Number: 894 • 2014 ACR/ARHP Annual Meeting
Small Fiber Neuropathy in Women with Fibromyalgia. a Clinical-Pathological Correlation Using Confocal Corneal Biomicroscopy
Manuel Ramírez-Fernández¹, Laura-Aline Martinez-Martinez², Angelica Vargas-Guerrero³, Manuel Martínez-Lavín⁴, Everardo Hernandez Quintela¹ and Jorge Velazco-Caspia¹, ¹Asociación para Evitar la Ceguera en México, Mexico City, Mexico, ²Instituto Nacional de Cardiologia, Mexico City, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia, Mexico City, Mexico, ⁴Chief Rheumatology, Instituto Nacional de Cardiologia, Mexico City, Mexico
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome (Semin Arthritis Rheum 2000;29:197). This view has been recently reinforced…
Abstract Number: 895 • 2014 ACR/ARHP Annual Meeting
The Fibromyalgia Syndrome and Widespread Pain Frequency in Active Duty U.S. Service Members with Posttraumatic Stress Disorder
Bernard Hildebrand¹, Jay B. Higgs¹, Douglas Williamson², Edna Foa³, Patricia Resick⁴, Jim Mintz², Antoinette Brundige², Kevin Kelly⁵, Adam Borah⁵, Stacey Young-McCaughan², Brett Litz⁶, Elizabeth Hembree³ and Alan Peterson², ¹Rheumatology, San Antonio Military Medical Center, JBSA - Fort Sam Houston, TX, ²The University of Texas Health Science Center at San Antonio, San Antonio, TX, ³University of Pennsylvania, Philadelphia, PA, ⁴Duke University, Durham, NC, ⁵Carl R. Darnall Army Medical Center, Fort Hood, TX, ⁶VA Boston Healthcare System, Boston, MA
Background/Purpose: Posttraumatic stress disorder (PTSD) and pain are common amongst US military service members who have deployed to Iraq and Afghanistan. Studies suggest the co-morbidity…
Abstract Number: 896 • 2014 ACR/ARHP Annual Meeting
Development of Fibromyalgia and Polysymptomatic Distress Definitions in the National Health Interview Survey
Brian Walitt¹, Richard Nahin², Robert S. Katz³, Martin J. Bergman⁴ and Frederick Wolfe⁵, ¹MedStar Health, Washington, DC, ²National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethedsa, MD, ³Rush Medical College, Chicago, IL, ⁴Taylor Hospital, Ridley Park, PA, ⁵National Data Bank for Rheumatic Diseases, Wichita, KS
Background/Purpose: A detailed understanding of fibromyalgia and its symptoms in the US population would be valuable. The National Health Interview Survey (NHIS) is the principal…
Abstract Number: 892 • 2014 ACR/ARHP Annual Meeting
Symptom Increase in Fibromyalgia Is Not Consistent with the Central Sensitization or Central Hyperresponsiveness Hypothesis
Frederick Wolfe¹, Brian T. Walitt², Johannes Rasker³, Robert S. Katz⁴ and Winfried Häuser⁵, ¹National Data Bank for Rheumatic Diseases, Wichita, KS, ²Rheumatology, Washington Hospital Center, Washington, DC, ³Dpt. Psychology, Health and Technology, University Twente, Enschede, Netherlands, ⁴Rush Medical College, Chicago, IL, ⁵Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: The current dominant hypothesis explains fibromyalgia (FM) as a centralized pain state in which the CNS originates or amplifies pain, which is then accompanied…
Abstract Number: 891 • 2014 ACR/ARHP Annual Meeting
Randomized Clinical Trial of Group Vs. Individual Physical Therapy for Knee Osteoarthritis
Kelli D. Allen¹, Dennis Bongiorni², Hayden B. Bosworth³, Cynthia Coffman³, Santanu Datta⁴, David Edelman³, Jennifer H. Lindquist⁵, Eugene Oddone³ and Helen Hoenig⁶, ¹Health Services Research, Durham VA Medical Center and University of North Carolina at Chapel Hill, Durham, NC, ²Durham VA Medical Center, Durham, NC, ³Health Services Research, Durham VA Medical Center and Duke University Medical Center, Durham, NC, ⁴Health Services Reserach, Durham VA Medical Center and Duke University Medical Center, Durham, NC, ⁵Health Services Research, Durham VA Medical Center, Durham, NC, ⁶Durham VA Medical Center and Duke University Medical Center, Durham, NC
Background/Purpose: Physical therapy (PT) is a key component of treatment for knee osteoarthritis (OA). There is a high demand for PT services in many healthcare…
Abstract Number: 890 • 2014 ACR/ARHP Annual Meeting
Test of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) 29-Item Profile in a Large Cohort of Rheumatic Disease Patients
Patricia P. Katz¹, Sofia Pedro² and Kaleb Michaud³, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²1035 N Emporia Ste 288, National Data Bank, Wichita, KS, ³University of Nebraska Medical Center and National Data Bank, Omaha, NE
Background/Purpose: Patient-reported outcomes are routinely used in rheumatology research and clinical care. Yet, often outcomes cannot be compared across studies or diseases because a variety…
Abstract Number: 889 • 2014 ACR/ARHP Annual Meeting
Exercise, Manual Therapy, and Use of Booster Sessions in Physical Therapy for Knee OA: A Multi-Center Randomized Clinical Trial
G Kelley Fitzgerald¹, Julie Fritz², John Childs³, Gerard P. Brennan⁴, Douglas P. Landsittel⁵, Brett Neilson⁶, Alexandra Gil¹ and J. Haxby Abbott⁷, ¹Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ²Physical Therapy, University of Utah, Salt Lake City, UT, ³US Army-Baylor University, Schertz, TX, ⁴Rehabilitation Services, Intermountain Healthcare, Murray, UT, ⁵Medicine, Biostatistics and Clinical and Translational Science, University of Pittsburgh, Center for Health Care Research Data Center, Pittsburgh, PA, ⁶Henry M. Jackson Foundation, Bethesda, MD, ⁷Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand
Background/Purpose: There is need to improve the magnitude and duration of treatment effects of exercise therapy (ET) for patients with knee osteoarthritis (KOA). There is…
Abstract Number: 888 • 2014 ACR/ARHP Annual Meeting
Annual Medical Care Expenditures Among US Adults with Gout, 2005 – 2011
Miriam G. Cisternas¹, Louise Murphy², David J. Pasta³, Edward H. Yelin⁴ and Charles Helmick⁵, ¹MGC Data Services, Carlsbad, CA, ²Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA, ³DMA Corporation, Palo Alto, CA, ⁴Arthritis Research Group, University of California, San Francisco, San Francisco, CA, ⁵Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Costs associated with gout are of growing interest due to its increasing prevalence, but quantifying those costs has been hampered by its co-occurrence with…
Abstract Number: 887 • 2014 ACR/ARHP Annual Meeting
Serological and Clinical Characteristics of a Large Collection of Incomplete Lupus Erythematosus Patients
Teresa Aberle¹, Virginia C. Roberts¹, Julie M. Robertson¹, Joel M. Guthridge¹, Kathy L. Sivils², Astrid Rasmussen², David R. Karp³ and Judith James⁴, ¹Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ³Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, ⁴Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Incomplete lupus (ILE) is defined as a condition in which patients present with signs of systemic autoimmunity and clinical manifestations compatible with systemic lupus…
Abstract Number: 886 • 2014 ACR/ARHP Annual Meeting
Measuring Rheumatoid Arthritis Remission: Which Index of Disease Activity Best Predicts Work Status?
Nancy A. Baker¹, Heather Eng², Juan (June) Feng², Jason Lyons², Yong Gil Hwang³, Kimberly P. Liang⁴ and Larry W. Moreland⁵, ¹Department of Occupational Therapy, University of Pittsburgh, Pittsburgh, PA, ²Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, ³Department of Medicine, University of Pittsburgh, Pittsburgh, PA, ⁴Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁵Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Disease remission is the goal of treat-to-target initiatives in rheumatoid arthritis (RA). There are multiple indices to measure disease activity and remission status including…
Abstract Number: 885 • 2014 ACR/ARHP Annual Meeting
A 2-Week Single-Blind, Randomized, 3-Arm Proof of Concept Study of the Effects of Secukinumab (anti-IL17 mAb), Canakinumab (anti-IL-1 b mAb), or Corticosteroids on Initial Disease Activity Scores in Patients with PMR, Followed By an Open-Label Extension to Assess Safety and Effect Duration
Eric L. Matteson¹, Bhaskar Dasgupta², Wolfgang A. Schmidt³, Carlo Salvarani⁴, Nagui Gendi⁵, Mauro Galeazzi⁶, Sylvie Stitah⁷, Yue Li⁸, Marie-Anne Valentin⁹, Bolan Linghu¹⁰ and Stephen J. Oliver⁷, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Rheumatology, Southend University Hospital, Essex, United Kingdom, ³Rheumatology, Immanuel Krankenhaus, Berlin, Germany, ⁴Rheumatology Unit, Arcispedale-Santa-Maria-Nuova, Reggio Emilia, Italy, ⁵Rheumatology, Basildon & Thurroch University Hospitals NHS Trust, Basildon, Essex, United Kingdom, ⁶Sezione di Reumatologia, Università di Siena, Siena, Italy, ⁷Translational Medicine, Novartis Pharma AG, Basel, Switzerland, ⁸IIS, Novartis Pharma AG, Basel, Switzerland, ⁹Biomarker Development, Novartis Pharma AG, Basel, Switzerland, ¹⁰Translational Medicine, Novartis Pharma AG, Cambridge, MA
Background/Purpose To assess the effects of a single dose of secukinumab or canakinumab in patients with new onset, untreated polymyalgia rheumatica (PMR). Methods In this…
Abstract Number: 884 • 2014 ACR/ARHP Annual Meeting
Interleukin 6 Does Not Upregulate Pro Inflammatory Cytokine Expression in an Ex-Vivo Model of Giant Cell Arteritis
Lorraine O'Neill¹, Jennifer McCormick², Wei Gao², Conor Murphy³, Geraldine M. McCarthy⁴, Douglas J. Veale⁵, Ursula Fearon² and Eamonn S. Molloy¹, ¹Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland, ²Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, ³Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland, ⁴Medicine/Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, ⁵Translational Rheumatology Research Group, St. Vincent's University Hospital, Dublin 4, Ireland
Background/Purpose Interleukin 6 (IL 6) is postulated to play a role in the pathogenesis of Giant Cell Arteritis. Several studies have demonstrated increased circulating IL…
Abstract Number: 883 • 2014 ACR/ARHP Annual Meeting
Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study
Maxime Rhéaume¹, Ryan Rebello², Christian Pagnoux³, Simon Carette³, Marie Clements-Baker⁴, Violette Cohen-Hallaleh², David Doucette-Preville², B. Stanley Jackson⁵, Sam Salama⁶, George Ioannidis⁷ and Nader A. Khalidi¹, ¹Division of Rheumatology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ²Department of Radiology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ³Division of Rheumatology, University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Queens University, Kingston, ON, Canada, ⁵Department of Surgery, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ⁶Department of Pathology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ⁷St Joseph's Healthcare Hamilton, Hamilton, ON, Canada
Background/Purpose: Temporal artery biopsy (TAB) remains the gold standard for the diagnosis of giant cell arteritis (GCA). It is invasive and its sensitivity is limited…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].